| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/22/2010 | US20100184067 Primer evaluation method, primer evaluation program, and real-time polymerase chain reaction apparatus |
| 07/22/2010 | US20100184042 Processes for quantitative or qualitative detection of single-stranded nucleic acids |
| 07/22/2010 | US20100184038 System and Method For the Heterologous Expression of Polyketide Synthase Gene Clusters |
| 07/22/2010 | US20100184021 Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis |
| 07/22/2010 | US20100184014 Non-M, non-O HIV-1 strains, fragments and uses |
| 07/22/2010 | US20100183765 Asparaginase enzyme variants and uses thereof |
| 07/22/2010 | US20100183750 Fortification of plants with folates by metabolic engineering |
| 07/22/2010 | US20100183733 Hair growth-inhibiting agent |
| 07/22/2010 | US20100183708 Antigen Delivery Vectors and Constructs |
| 07/22/2010 | US20100183705 Phospholipid-analogous compounds |
| 07/22/2010 | US20100183704 dsRNA FOR TREATING VIRAL INFECTION |
| 07/22/2010 | US20100183703 Pharmaceutical or cosmetic composition containing a double stranded rna oligonucleotide and its use as an active pharmaceutical ingredient in the treatment of androgen related diseases |
| 07/22/2010 | US20100183696 Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists |
| 07/22/2010 | US20100183673 Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| 07/22/2010 | US20100183666 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 07/22/2010 | US20100183665 Promoterless cassettes for expression of alpha virus structural proteins |
| 07/22/2010 | US20100183654 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 07/22/2010 | US20100183653 Fusion Proteins Comprising CD4 Minimal Modules and Methods of Use Thereof |
| 07/22/2010 | US20100183651 Broadly Representative Antigen Sequences and Method for Selection |
| 07/22/2010 | US20100183647 Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 07/22/2010 | US20100183645 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 07/22/2010 | US20100183644 Tumour-Associated Peptides that Bind to MHC Molecules |
| 07/22/2010 | US20100183640 Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production |
| 07/22/2010 | US20100183639 Nucleic acid-lipophilic conjugates |
| 07/22/2010 | US20100183637 fusion molecule based on novel taa variant |
| 07/22/2010 | US20100183616 Antibodies against interleukin-1 beta |
| 07/22/2010 | US20100183615 Cross-species-specific bispecific binders |
| 07/22/2010 | US20100183612 Methods of treatment using ctla4 mutant molecules |
| 07/22/2010 | US20100183611 Targeted cryptosporidium biocides |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/22/2010 | US20100183595 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
| 07/22/2010 | US20100183590 LSA-5 liver stage and blood stage antigen of Plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 07/22/2010 | US20100183589 Human blood proteins expressed in monocot seeds |
| 07/22/2010 | US20100183588 Mutated Netrin-4, Fragments Thereof And Their Use As Medicines |
| 07/22/2010 | US20100183577 Enzyme replacement therapy for treating lysosomal storage diseases |
| 07/22/2010 | US20100183573 membrane polypeptide for use in designing therapeutic for proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders; cancer, immunological-related, blood-related and skin-related disorders |
| 07/22/2010 | US20100183572 Cell capable of expressing lacritin at high level |
| 07/22/2010 | US20100183558 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules |
| 07/22/2010 | US20100183557 Ptra gene and uses thereof |
| 07/22/2010 | US20100183556 Recombinant expression vector system for variants of coagulation factor VIII and von Willebrand factor |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183516 Self coupling recombinant antibody fusion proteins |
| 07/22/2010 | US20100181035 Glucosyltransferases |
| 07/22/2010 | DE112008002435T5 Pflanzen mit erhöhtem Ertrag Plants with increased yield |
| 07/22/2010 | CA2749862A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/22/2010 | CA2749824A1 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes |
| 07/22/2010 | CA2749693A1 Enzyme preparation containing thermostable dna polymerase, method for producing same, and method for detecting subject organism to be detected |
| 07/22/2010 | CA2749571A1 Fusion proteins, preparation process thereof and their use in recombinant protein expression systems |
| 07/22/2010 | CA2749396A1 A method for increasing protein expression in cells |
| 07/21/2010 | EP2209075A1 Base sequence determination program, base sequence determination system and base sequence determination method |
| 07/21/2010 | EP2209000A2 Detection, monitoring and treatment of cancer |
| 07/21/2010 | EP2208796A2 Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification |
| 07/21/2010 | EP2208795A1 Nucleic acid detection method, and nucleic acid detection kit |
| 07/21/2010 | EP2208793A1 Protein providing inducible resistance to glycopeptides, in particular in gram-positive bacteria |
| 07/21/2010 | EP2208792A2 Polypeptide producing cells |
| 07/21/2010 | EP2208791A1 Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) and herbicide-tolerant plants containing it |
| 07/21/2010 | EP2208790A1 Plants producing 2N gametes or apomeiotic gametes |
| 07/21/2010 | EP2208789A1 DNA polymerases having improved labeled nucleotide incorporation properties |
| 07/21/2010 | EP2208788A1 MANIPULATION OF THE FUNCTION OF AtDBP1 IN ORDER TO GENERATE POTYVIRUS RESISTANCE |
| 07/21/2010 | EP2208787A1 A recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 07/21/2010 | EP2208786A1 Nuclear reprogramming factor |
| 07/21/2010 | EP2208785A1 Methods and kits to generate miRNA- and smallRNA-expressing vectors, and its application to develop lentiviral expression libraries |
| 07/21/2010 | EP2208784A1 Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 07/21/2010 | EP2208737A1 Complement factor H-derived short consensus repeat-antibody constructs |
| 07/21/2010 | EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer |
| 07/21/2010 | EP2208499A1 Nucleic acid capable of regulating the proliferation of cell |
| 07/21/2010 | EP2207891A2 Materials and methods for the generation of transcripts comprising modified nucleotides |
| 07/21/2010 | EP2207884A1 Regulatory elements associated with cbf transcription factor of rye |
| 07/21/2010 | EP2207882A1 Cho-k1 cell line |
| 07/21/2010 | EP2207881A1 Protein expression from multiple nucleic acids |
| 07/21/2010 | EP2207880A1 Catenate for immunostimulation |
| 07/21/2010 | EP2207879A2 Identification and isolation of fetal cells and nucleic acid |
| 07/21/2010 | EP2207877A2 Mutant enzymes |
| 07/21/2010 | EP2207874A1 Engineered dendritic cells and uses for the treatment of cancer |
| 07/21/2010 | EP2207797A1 Modulation of sirpalpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 07/21/2010 | EP2207794A1 Compositions and methods for making androstenediones |
| 07/21/2010 | EP2207785A1 Method, substances and kits for labeling populations of rna and other subtances containing geminal diols |
| 07/21/2010 | EP2207563A1 Preventive and therapeutic vaccine for stroke and neurological disorders |
| 07/21/2010 | EP2207555A1 Novel compounds for the treatment or alleviation of edema, and methods for their use |
| 07/21/2010 | EP2007885B1 Method of increasing the in vivo recovery of therapeutic polypeptides |
| 07/21/2010 | EP1885880B1 Amplification and cloning of single dna molecules using rolling circle amplification |
| 07/21/2010 | EP1727901B1 Materials and methods for treatment of cancer |
| 07/21/2010 | EP1581056B1 Therapeutic retroviral vectors for gene therapy |
| 07/21/2010 | EP1417493B1 Competitive binding assay for identifying inhibitors of hcv polymerase |
| 07/21/2010 | EP1412502B1 Use of clya hemolysin for excretion of fusion proteins |
| 07/21/2010 | EP1369476B1 A novel protein, a gene encoding therefor and a method of using the same |
| 07/21/2010 | EP1276896B1 Epitope synchronization in antigen presenting cells |
| 07/21/2010 | EP1161537B2 Non-spreading pestivirus |
| 07/21/2010 | EP1124961B9 Thrombopoietic compounds |
| 07/21/2010 | EP0724642B2 Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN1982456B China amphioxus peptidoglycan recognition protein B.b.PGRP, its production and use |
| 07/21/2010 | CN1876813B Method for improving cold resistance of zoysia |
| 07/21/2010 | CN1685039B Secreted acid phosphatase (SAPM) is present only in pathogenic mycobacteria and expressed selectively at phagosomal PH |
| 07/21/2010 | CN101784673A epigenetic methods |
| 07/21/2010 | CN101784667A Secondary wall forming genes from maize and uses thereof |
| 07/21/2010 | CN101784666A A recombinant host cell for the production of a compound of interest |
| 07/21/2010 | CN101784665A Mutant of propionyl-coa transferase from clostridium propionicum and preparing method for pla or pla copolymer using the same |
| 07/21/2010 | CN101784664A Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies |
| 07/21/2010 | CN101784663A Methods for isolating long fragment rna from fixed samples |